Maria C Carrillo PhD

Chief Science Officer & Medical Affairs Lead

[Maria C Carrillo PhD @DrMariaALZ]

U.S. POINTER proved the power of lifestyle changes to protect brain health. Now, our new (re)think your brain movement translates that rigorous research into real‑world action. Join us at at https://t.co/HpFvQtReIt.

[Joanne Pike, DrPH @joannepikedrph]

The @alzassociation is launching a bold new effort to improve brain health: (re)think your brain. Our science shows everyday habits — how you move, eat, and challenge your mind — can protect memory and support long‑term brain health. Start today: https://t.co/ktkwg8T9D3

[Maria C Carrillo PhD @DrMariaALZ]

This reflects an important model of innovation — finding new ways existing drugs can help people living with Alzheimer's disease — and underscores the power of science to make an impact on people and families. Learn more below about this new option for managing agitation.

[Alzheimer's Association @alzassociation]

Today, the FDA approved the first non-antipsychotic treatment for Alzheimer’s disease agitation — an important step forward for a symptom that is among the most challenging to manage in care. Read our statement >> https://t.co/ykitkmpuN4

[Maria C Carrillo PhD @DrMariaALZ]

Proud to announce new Part the Cloud investments: $11 million in 11 studies developing potential new treatments for Alzheimer’s and other diseases that cause dementia. This brings our total PTC investment to $90m+.
More: https://t.co/davp6LiebD

[ISTAART @ISTAART]

🔔Applications close for the ISTAART Ambassador Program next week!🔔

The program provides early-career individuals with access to #AAIC26 and year-round professional development, networking and mentoring.

Visit https://t.co/Pb71EZPMpD to apply before Jan 16!

@alzassociation

[The Rainwater Charitable Foundation @RCFNeuro]

🚨 Deadline: January 16. Submit your LOI for the Sprint-to-Lead (S2L) Program. We are accelerating the development of therapies for primary tauopathies in the hit-to-lead and lead optimization phases of drug discovery. Learn more: https://t.co/q2bYuD20Mj

[Maria C Carrillo PhD @DrMariaALZ]

So honored to have brougt together the U.S. POINTER trial with @HeatherAlz & team led by Dr. Laura Baker and others! Impact is clear, our article was included in JAMA's Research of the Year. We are among the most influential studies of the year, congratulations! @Prof_R_Whitmer

[JAMA @JAMA_current]

Introducing JAMA’s Research of the Year.

Chosen by JAMA editors, the inaugural roundup highlights 9 of the most impactful, newsworthy, and novel studies published in the journal over the past year. 🧵

#JAMAROTY25

🔗 https://t.co/zvpFrvH0Os

[Maria C Carrillo PhD @DrMariaALZ]

Proud mom moment!!! Congratulations Maricarmen, so proud of my neuroscientist!!

[Maricarmen Pachicano @mc_pachicano]

🎉 Super excited to share our new paper in Nature Communications — my first first-author publication!
We reveal a hidden laminar architecture within the hippocampal CA1 that spans the entire dorsal—ventral axis.
🧠✨
👇
📄https://t.co/E26DtcHWF5

[Maria C Carrillo PhD @DrMariaALZ]

Evidence keeps growing that lifestyle impacts not just brain health, but overall health, too. The @alzassociation is proud to be part of the team leading this important work. We look forward to digging deeper into the data to learn even more about the studies’ findings!

[Alzheimer's Association @alzassociation]

U.S. POINTER Update: Three @NIHAging-funded ancillary studies report structured healthy lifestyle program previously shown to improve cognition may also improve sleep apnea, blood pressure regulation and cognitive resilience. Read the full release> https://t.co/Ad9xKYw2Ck
#CTAD25 #AlzResearch

[Alzheimer's Association @alzassociation]

Research update 🔬: The evoke and evoke+ clinical trials testing an oral semaglutide pill (GLP-1 drug) to treat early Alzheimer’s did not demonstrate a statistically significant reduction in disease progression. 

While we are disappointed in the results, these studies provide valuable insights that will guide future research into new, non-amyloid treatment approaches.

Read our full statement: https://t.co/kvGMvAdyZc.

[Alzheimer's Association @alzassociation]

It can be overwhelming to take care of a loved one with Alzheimer's or other dementia, but too much stress can be harmful. It’s important to take care of yourself. 💜 Get our tips at https://t.co/GullnRsSsr. #NationalFamilyCaregiversMonth

[Maria C Carrillo PhD @DrMariaALZ]

ISTAART is monitoring the potential impact of the government shutdown on researchers & the dementia care community where funds & staffing capacity are critical.

Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!

[Maria C Carrillo PhD @DrMariaALZ]

Proud to share the Alzheimer’s Association invested $112.2M in research activities over the last year — our largest single-year commitment. From gene therapy to #BrainHealth to risk reduction to AI, we’re funding bold boundary-pushing ideas. https://t.co/fZbvhSMW15

#ENDALZ

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

Inspiring plenary by Juan Fortea at #AAIC2025 on #Alzheimer’s in Down syndrome. He highlighted the partnership with @GBHI_Fellows to reach those with the least access. That’s the spirit — teamwork to reduce brain health inequities across the globe! 🌍🧠

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

Sleep is one of the earliest systems to go awry in neurodegenerative diseases—yet remains vastly under-recognized and under-studied. Excited for Sharon Naismith's #AAIC2025 plenary: a wake-up call to the field on why sleep matters🧠💤 #sleepresearch #Dementia @SleepPIA @ISTAART

[Alzheimer's Association @alzassociation]

🏆 Bruce Lamb, Ph.D., is the 2025 recipient of the Zaven Khachaturian Award.

This award recognizes an individual whose compelling vision, selfless dedication and extraordinary achievement has significantly advanced the field of Alzheimer’s science.

Dr. Lamb is a basic and translational scientist with a focus on animal models of Alzheimer’s disease and preclinical therapeutic testing, including his leadership roles on the National Institute of Aging (NIA)-funded MODEL-AD Center and the TREAT-AD Center.

@IndianaUniv @IUMedSchool @IUStark_Neuro #AAIC25

[Global Brain Health Institute @GBHI_Fellows]

The @alzassociation International Conference #AAIC25 is happening now through July 31, and @GBHI_Fellows is there! 🧠
Join us to learn more about our work, connect with @atlanticfellows, and explore our fellowship program.
Full details👉 https://t.co/0FCBo2oKRI

[GAAIN @alzGAAIN]

Check out our #Centiloid #metaanalysis poster today on day 3 of #AAIC25! Learn more about how the GAAIN Interrogator can be used to discover datasets for secondary analyses 📈

See you at our #smallposter with #bigdata over at 377!

[Maria C Carrillo PhD @DrMariaALZ]

news from #AAIC25 marks a moment so many of us in the Alzheimer’s and dementia scientific community have long hoped for. We can now say with confidence that lifestyle interventions can protect brain health in diverse communities in the U.S.

[Alzheimer's Association @alzassociation]

📣 Today is a turning point in what we know about brain health.

The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.

The findings, shared for the first time today at #AAIC25, tested lifestyle programs that simultaneously targeted risk factors. The programs focused on:

✅👟Aerobic exercise
✅🧠Cognitive engagement
✅🥗Nutrition
✅🫀Health Monitoring

U.S. POINTER is the largest research commitment the Association has made in its history. The landmark results are testament to our commitment to our mission. Thank you to the study participants, our community, our donors, and the staff who made these findings possible.

https://t.co/RDqYXQl0Kq

[Alzheimer's Association @alzassociation]

📣 Today is a turning point in what we know about brain health.

The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.

The findings, shared for the first time today at #AAIC25, tested lifestyle programs that simultaneously targeted risk factors. The programs focused on:

✅👟Aerobic exercise
✅🧠Cognitive engagement
✅🥗Nutrition
✅🫀Health Monitoring

U.S. POINTER is the largest research commitment the Association has made in its history. The landmark results are testament to our commitment to our mission. Thank you to the study participants, our community, our donors, and the staff who made these findings possible.

https://t.co/RDqYXQl0Kq

[Maria C Carrillo PhD @DrMariaALZ]

“This is just the beginning,” @BillGates wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more momentum than ever before, but now we need to go faster, earlier and bolder. That’s what @ALZAssocation’s Part the Cloud is all about.

[Alzheimer's Association @alzassociation]

On his blog, @BillGates shares his hope for—and commitment to—the fight to #ENDALZ, highlighting his support for the Association’s #PartTheCloud initiative, which funds high-risk, high-reward clinical trials aimed at accelerating scientific breakthroughs. https://t.co/olXJKnXV8E